Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

Nowadays; intravitreal anti-vascular endothelial growth factor (VEGF) drugs are considered the first-line therapeutic strategy for treating macular exudative diseases; including wet age-related macular degeneration (w-AMD) and diabetic macular edema (DME). Despite the important clinical achievements...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferro Desideri, Lorenzo, Traverso, Carlo Enrico, Nicolò, Massimo, Munk, Marion R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222467/
https://www.ncbi.nlm.nih.gov/pubmed/37242655
http://dx.doi.org/10.3390/pharmaceutics15051413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222467/
https://www.ncbi.nlm.nih.gov/pubmed/37242655
http://dx.doi.org/10.3390/pharmaceutics15051413

Ejemplares similares